These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16721833)

  • 1. Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.
    Dedoussis GV; Maumus S; Skoumas J; Choumerianou DM; Pitsavos C; Stefanadis C; Visvikis-Siest S
    J Clin Lab Anal; 2006; 20(3):98-104. PubMed ID: 16721833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia.
    Pitsavos C; Choumerianou DM; Skoumas J; Maumus S; Stefanadis C; Dedoussis GV; Visvikis-Siest S
    Clin Exp Med; 2005 Dec; 5(4):196-201. PubMed ID: 16362800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
    Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR
    Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients.
    Dedoussis GV; Maumus S; Choumerianou DM; Skoumas J; Pitsavos C; Stefanadis C; Visvikis-Siest S
    Genet Test; 2006; 10(3):192-9. PubMed ID: 17020471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
    Trinder M; Cermakova L; Ruel I; Baass A; Paquette M; Wang J; Kennedy BA; Hegele RA; Genest J; Brunham LR
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1683-1693. PubMed ID: 38779854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia.
    Bertolini S; Pisciotta L; Di Scala L; Langheim S; Bellocchio A; Masturzo P; Cantafora A; Martini S; Averna M; Pes G; Stefanutti C; Calandra S
    Atherosclerosis; 2004 May; 174(1):57-65. PubMed ID: 15135251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Association Study Identifies a Functional
    León-Mimila P; Villamil-Ramírez H; Macías-Kauffer LR; Jacobo-Albavera L; López-Contreras BE; Posadas-Sánchez R; Posadas-Romero C; Romero-Hidalgo S; Morán-Ramos S; Domínguez-Pérez M; Olivares-Arevalo M; López-Montoya P; Nieto-Guerra R; Acuña-Alonzo V; Macín-Pérez G; Barquera-Lozano R; Del-Río-Navarro BE; González-González I; Campos-Pérez F; Gómez-Pérez F; Valdés VJ; Sampieri A; Reyes-García JG; Carrasco-Portugal MDC; Flores-Murrieta FJ; Aguilar-Salinas CA; Vargas-Alarcón G; Shih D; Meikle PJ; Calkin AC; Drew BG; Vaca L; Lusis AJ; Huertas-Vazquez A; Villarreal-Molina T; Canizales-Quinteros S
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2494-2508. PubMed ID: 34233476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
    Benn M; Watts GF; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3956-64. PubMed ID: 22893714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.
    Brænne I; Kleinecke M; Reiz B; Graf E; Strom T; Wieland T; Fischer M; Kessler T; Hengstenberg C; Meitinger T; Erdmann J; Schunkert H
    Eur J Hum Genet; 2016 Feb; 24(2):191-7. PubMed ID: 26036859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease.
    Liao B; Cheng K; Dong S; Liu H; Xu Z
    Diagn Pathol; 2015 Jul; 10():102. PubMed ID: 26173491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the atrial natriuretic peptide rs5065 gene polymorphism and the presence and severity of coronary artery disease in an Iranian population.
    Ziaee S; Kalayinia S; Boroumand MA; Pourgholi L; Cheraghi S; Anvari MS; Sheikhvatan M
    Coron Artery Dis; 2014 May; 25(3):242-6. PubMed ID: 24487939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    J Clin Lipidol; 2018; 12(4):966-971. PubMed ID: 29784573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis.
    Ellis KL; Pang J; Chieng D; Bell DA; Burnett JR; Schultz CJ; Hillis GS; Watts GF
    Clin Cardiol; 2018 Mar; 41(3):378-384. PubMed ID: 29480541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic and genetic variations at the TNNT1 gene locus are associated with HDL-C levels and coronary artery disease.
    Guay SP; Légaré C; Brisson D; Mathieu P; Bossé Y; Gaudet D; Bouchard L
    Epigenomics; 2016 Mar; 8(3):359-71. PubMed ID: 26950807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia.
    Choumerianou DM; Maumus S; Skoumas J; Pitsavos C; Stefanadis C; Visvikis-Siest S; Dedoussis GV
    Clin Chem Lab Med; 2006; 44(7):799-806. PubMed ID: 16776623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.